Auteur B. HAJARIZADEH

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all

J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : Périodique

There have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]

Plus d'info

Ajouter à la sélection

Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique

BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]

Plus d'info

Ajouter à la sélection

Lien externe

Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique

BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]

Plus d'info

Ajouter à la sélection

Lien externe

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : Périodique

Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]

Plus d'info

Ajouter à la sélection

Lien externe

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review

S. BAJIS ; G. J. DORE ; B. HAJARIZADEH ; E. B. CUNNINGHAM ; L. MAHER ; J. GREBELY | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Background: The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to[...]

Plus d'info

Ajouter à la sélection

Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis

C. MACDONALD ; G. MACPHERSON ; O. LEPPAN ; L. T. TRAN ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. GREBELY ; M. FARRELL ; F. L. ALTICE ; L. DEGENHARDT | 2024
Dans Lancet Public Health (The) (Vol.9, n°9, September 2024) Article : Périodique

Background: Mortality, suicide, self-harm, and substance use are elevated among people who are incarcerated. There is a wide range of heterogeneous interventions aimed at reducing these harms in this population. Previous reviews have focused on [...]

Plus d'info

Ajouter à la sélection

Lien externe

International Journal of Drug Policy, Vol.72 - October 2019 - Striving towards the elimination of HCV infection among PWID

J. GREBELY, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; J. BRUNEAU, Éditeur scientifique ; J. V. LAZARUS, Éditeur scientifique ; B. HAJARIZADEH, Éditeur scientifique | 2019
Bulletin : Périodique

Plus d'info

Ajouter à la sélection

Lien externe

Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake

L. LAFFERTY ; F. L. ALTICE ; F. LEONE ; M. STOOVE ; A. R. LLOYD ; B. HAJARIZADEH ; N. KRONFLI | 2024
Dans International Journal of Drug Policy (Vol.131, September 2024) Article : Périodique

Background: Prison needle exchange programs (PNEPs) are a critical component for harm reduction in prisons. Little is known about the PNEP access barriers for people who are incarcerated, but the low uptake in the Canadian program highlights the[...]

Plus d'info

Ajouter à la sélection

Lien externe